Diluted earnings per share for the quarter were 96 cents per share while revenues were $11.9 billion. The company returned $244 million to shareholders in the form of dividends and share repurchases. Eli Lilly chief scientific officer bought 5,000 shares Senior Vice President, CSO and President Daniel Skovronsky bought 5,000 shares on Oct. 25 for an average price of $108.61. The stock has gained 3.59% since then. Eli Lilly is an American international pharmaceutical company with offices in 18 countries and products sold in more than 120 countries.